These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 27500474)

  • 41. The cost-effectiveness of introducing nucleic acid testing to test for hepatitis B, hepatitis C, and human immunodeficiency virus among blood donors in Sweden.
    Davidson T; Ekermo B; Gaines H; Lesko B; Åkerlind B
    Transfusion; 2011 Feb; 51(2):421-9. PubMed ID: 20849409
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatitis B virus and hepatitis C virus infection among HIV-1-infected injection drug users in Dali, China: prevalence and infection status in a cross-sectional study.
    Dong Y; Qiu C; Xia X; Wang J; Zhang H; Zhang X; Xu J
    Arch Virol; 2015 Apr; 160(4):929-36. PubMed ID: 25616842
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Seropositivity of hepatitis C, hepatitis B and HIV in chronically transfused β-thalassaemia major patients.
    Ansari SH; Shamsi TS; Khan MT; Perveen K; Farzana T; Erum S; Ansari I
    J Coll Physicians Surg Pak; 2012 Sep; 22(9):610-1. PubMed ID: 22980623
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence of positive HIV, HBV, HCV and treponemal tests in blood donors in a rural hospital in southern Ethiopia.
    Ramos JM; Tissiano G; Fano H; Yohannes T; Gosa A; Reyes F; Górgolas M; Barreiro P
    J Clin Virol; 2016 Apr; 77():60-2. PubMed ID: 26896875
    [No Abstract]   [Full Text] [Related]  

  • 45. Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus.
    Seed CR; Kiely P; Keller AJ
    Intern Med J; 2005 Oct; 35(10):592-8. PubMed ID: 16207258
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Incorporating HIV/hepatitis B virus/hepatitis C virus combined testing into routine blood tests in nine UK Emergency Departments: the "Going Viral" campaign.
    Orkin C; Flanagan S; Wallis E; Ireland G; Dhairyawan R; Fox J; Nandwani R; O'Connell R; Lascar M; Bulman J; Reeves I; Palfreeman A; Foster GR; Ahmad K; Anderson J; Tong CY; Lattimore S
    HIV Med; 2016 Mar; 17(3):222-30. PubMed ID: 26919291
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HIV, HBV, HCV, and syphilis co-infections among patients attending the STD clinics of district hospitals in Northern India.
    Hussain T; Kulshreshtha KK; Sinha S; Yadav VS; Katoch VM
    Int J Infect Dis; 2006 Sep; 10(5):358-63. PubMed ID: 16678462
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nationwide nucleic acid amplification testing of hepatitis B virus, hepatitis C virus and human immunodeficiency virus type 1 for blood transfusion and follow-up study of nucleic acid amplification positive donors.
    Japanese Red Cross NAT Screening Research Group
    Jpn J Infect Dis; 2000 Jun; 53(3):116-23. PubMed ID: 10957709
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Occurrence of occult HCV infection among Hiv infected patients in Georgia.
    Gatserelia L; Sharvadze L; Karchava M; Dolmazashvili E; Tsertsvadze T
    Georgian Med News; 2014 Jan; (226):37-41. PubMed ID: 24523330
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Viral co-infections and paraproteins in HIV: effect on development of hematological malignancies.
    Jou E; Gligich O; Chan AC; Mohan D; Felsen UR; Ayyappan S; Billett HH; Hui EP; Chan AT; Raghupathy R
    Ann Hematol; 2016 Mar; 95(4):575-80. PubMed ID: 26747296
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serological markers of hepatitis B and C in patients with HIV/AIDS and active tuberculosis.
    Araújo-Mariz C; Lopes EP; Ximenes RA; Lacerda HR; Miranda-Filho DB; Montarroyos UR; Barreto S; Salustiano DM; Albuquerque MF
    J Med Virol; 2016 Jun; 88(6):996-1002. PubMed ID: 26580855
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatitis B, C and HIV co-infections seroprevalence in a northeast Brazilian center.
    Távora LG; Hyppolito EB; Cruz JN; Portela NM; Pereira SM; Veras CM
    Arq Gastroenterol; 2013; 50(4):277-80. PubMed ID: 24474229
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Testing times.
    Lancet HIV
    Lancet HIV; 2015 Nov; 2(11):e451. PubMed ID: 26520919
    [No Abstract]   [Full Text] [Related]  

  • 54. [The epidemiological trends connected with detection of HIV, HCV, HBV and syphilis markers in blood donors in the years 2006-2009].
    Rudowska E; Basta L; Piwowarska G; Drybańska B; Dylag S
    Pol Merkur Lekarski; 2011 Mar; 30(177):181-6. PubMed ID: 21544994
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Seroprevalence and diagnosis of HIV, HBV, HCV and syphilis infections among blood donors.
    Tafesse TB; Gebru AA; Gobalee S; Belay GD; Belew MT; Ataro D; Ebrahim BA; Shebeshi GM; Yimam Y
    Hum Antibodies; 2017; 25(1-2):39-55. PubMed ID: 28009328
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Seroprevalence of multiple sexually transmitted infections among antenatal clinic attendees in Gondar Health Center, northwest Ethiopia.
    Tiruneh M
    Ethiop Med J; 2008 Oct; 46(4):359-66. PubMed ID: 19271400
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HIV liver disease: the Indian scenario.
    Meisheri YV
    Indian J Gastroenterol; 1997 Oct; 16(4):162-3. PubMed ID: 9357201
    [No Abstract]   [Full Text] [Related]  

  • 58. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
    Hourfar MK; Jork C; Schottstedt V; Weber-Schehl M; Brixner V; Busch MP; Geusendam G; Gubbe K; Mahnhardt C; Mayr-Wohlfart U; Pichl L; Roth WK; Schmidt M; Seifried E; Wright DJ;
    Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Seroprevalence of viral markers among blood donors at the Blood Donor Center of Mohammed V Military Teaching Hospital of Rabat, Morocco].
    Uwingabiye J; Zahid H; Unyendje L; Hadef R
    Pan Afr Med J; 2016; 25():185. PubMed ID: 28292147
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mini review: current molecular methods for the detection and quantification of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus type 1.
    Albertoni G; Castelo Girão MJ; Schor N
    Int J Infect Dis; 2014 Aug; 25():145-9. PubMed ID: 24927665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.